Screener
USANA Health Sciences USNA Shares (Diluted)
Discontinued — last reported Q1 '26
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:35 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000896264-26-000034
| Line item | Three months ended / April 4,2026 | Three months ended / March 29,2025 |
|---|---|---|
| Diluted | $0.41 | $0.49 |
| Weighted average common shares outstanding | ||
| Basic | 18,398 | 19,049 |
| Diluted | 18,411 | 19,085 |
| Comprehensive income (loss): | ||
| Net earnings | $6,959 | $9,290 |
| Other comprehensive income (loss), net of tax: | ||
| Foreign currency translation adjustment | 1,878 | 125 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is USANA Health Sciences's shares (diluted)?
- USANA Health Sciences (USNA) reported shares (diluted) of 18.4M in Q1 2026.
- How has USANA Health Sciences's shares (diluted) changed year-over-year?
- USANA Health Sciences's shares (diluted) decreased by 3.5% year-over-year, from 19.1M to 18.4M.
- What is the long-term trend for USANA Health Sciences's shares (diluted)?
- Over 3 years (2022 to 2025), USANA Health Sciences's shares (diluted) has grown at a -1.2% compound annual growth rate (CAGR), from 77.3M to 74.5M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about USANA Health Sciences's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude